Harmit J. Singh - 25 Mar 2019 Form 4/A - Amendment Insider Report for LEVI STRAUSS & CO (LEVI)

Signature
/s/ Priscilla Duncan-Tannous, Attorney-in-Fact
Issuer symbol
LEVI
Transactions as of
25 Mar 2019
Net transactions value
$0
Form type
4/A - Amendment
Filing time
21 Apr 2023, 18:30:28 UTC
Date Of Original Report
27 Mar 2019
Next filing
21 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEVI Common Stock Other $0 -6,050 -5.4% $0.000000 105,930 25 Mar 2019 Direct F1
transaction LEVI Common Stock Other $0 -105,930 -100% $0.000000* 0 25 Mar 2019 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEVI Class B Common Stock Other $0 +6,050 $0.000000 6,050 25 Mar 2019 Class A Common Stock 6,050 Direct F1
transaction LEVI Class B Common Stock Other $0 +105,930 +1751% $0.000000 111,980 25 Mar 2019 Class A Common Stock 105,930 Direct F1, F2, F3
transaction LEVI Stock Appreciation Rights Other $0 -976,390 -100% $0.000000* 0 25 Mar 2019 Common Stock 976,390 $6.10 Direct F1, F4, F5
transaction LEVI Stock Appreciation Rights Other $0 +976,390 $0.000000 976,390 25 Mar 2019 Class B Common Stock 976,390 $6.10 Direct F1, F4, F5
transaction LEVI Stock Appreciation Rights Other $0 -792,450 -100% $0.000000* 0 25 Mar 2019 Common Stock 792,450 $7.42 Direct F1, F4, F6
transaction LEVI Stock Appreciation Rights Other $0 +792,450 $0.000000 792,450 25 Mar 2019 Class B Common Stock 792,450 $7.42 Direct F1, F4, F6
transaction LEVI Stock Appreciation Rights Other $0 -660,790 -100% $0.000000* 0 25 Mar 2019 Common Stock 660,790 $6.45 Direct F1, F4, F7
transaction LEVI Stock Appreciation Rights Other $0 +660,790 $0.000000 660,790 25 Mar 2019 Class B Common Stock 660,790 $6.45 Direct F1, F4, F7
transaction LEVI Stock Appreciation Rights Other $0 -246,210 -100% $0.000000* 0 25 Mar 2019 Common Stock 246,210 $3.78 Direct F1, F4, F8
transaction LEVI Stock Appreciation Rights Other $0 +246,210 $0.000000 246,210 25 Mar 2019 Class B Common Stock 246,210 $3.78 Direct F1, F4, F8
transaction LEVI Stock Appreciation Rights Other $0 -89,440 -100% $0.000000* 0 25 Mar 2019 Common Stock 89,440 $14.88 Direct F1, F4, F9
transaction LEVI Stock Appreciation Rights Other $0 +89,440 $0.000000 89,440 25 Mar 2019 Class B Common Stock 89,440 $14.88 Direct F1, F4, F9
transaction LEVI Stock Appreciation Rights Other $0 -138,670 -100% $0.000000* 0 25 Mar 2019 Common Stock 138,670 $9.60 Direct F1, F4, F10
transaction LEVI Stock Appreciation Rights Other $0 +138,670 $0.000000 138,670 25 Mar 2019 Class B Common Stock 138,670 $9.60 Direct F1, F4, F10
transaction LEVI Stock Appreciation Rights Other $0 -216,980 -100% $0.000000* 0 25 Mar 2019 Common Stock 216,980 $6.90 Direct F1, F4, F11
transaction LEVI Stock Appreciation Rights Other $0 +216,980 $0.000000 216,980 25 Mar 2019 Class B Common Stock 216,980 $6.90 Direct F1, F4, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F2 This Form 4/A is being filed to correct the disclosure relating to RSUs set forth in the Form 4 filed on March 27, 2019 (the "Original Form 4"), which were inadvertently disclosed in Table I instead of Table II in the Original Form 4. As a result, certain subsequent instances of withholding of shares to satisfy tax liabilities were reported solely within Table I.
F3 Each share is represented by a restricted stock unit (RSU) that may be settled in shares of Class B Common Stock. Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Of these RSUs, (i) 50,720 RSUs vest on February 1, 2020, (ii) 28,320 RSUs vest in four equal annual installments beginning on January 30, 2019, and (iii) 26,890 RSUs vest in four equal annual installments beginning on January 30, 2020.
F4 Each stock appreciation right (SAR) represents the right to receive, upon exercise, shares of the Issuer's Common Stock (and, after the conversion noted in footnote (1), Class B Common Stock) with a value equal to the increase in the fair market value of one share of such stock from the date of grant of the SAR.
F5 Of these SARs: (i) 443,810 are performance stock appreciation rights (PSARs) that vested on January 30, 2019 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 532,580 SARs that vested as to 25% of the SARs on February 9, 2017, with the remainder vesting in 36 equal monthly installments thereafter.
F6 Of these SARs: (i) 337,020 are PSARs that vested on January 30, 2018 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 455,430 SARs that are fully vested.
F7 Of these SARs: (i) 220,270 are PSARs that vested on February 1, 2017 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 440,520 SARs that are fully vested.
F8 These SARs are PSARs that vested on March 1, 2016 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors.
F9 25% of the SARs vest on January 30, 2020, and 1/3 of the remaining SARs vest annually beginning on January 30, 2021.
F10 25% of the SARs vested on January 30, 2019, and 1/3 of the remaining SARs vest annually beginning on January 30, 2020.
F11 25% of the SARs vested on February 1, 2018, and 1/3 of the remaining SARs vest annually beginning on February 1, 2019.